Pimea AI

A personalized healthcare app (mHealth) for allergies that accesses the subconscious mind to retrain the immune system to avoid, or reduce, allergy inflammation.

Health Tech & Life Sciences
Active
Pre-Funding Tel Aviv-Yafo, Israel Founded 2022
Website ↗
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2022
Headcount
3
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Pimea AI is developing a digital personalized healthcare therapy to revolutionize the global allergy industry. Their nonintrusive solution leverages alternative medicine therapies and techniques to overcome allergies. The solution utilizes advanced algorithms that analyze patients' physiological parameters to autonomously administer a proprietary therapeutic protocol that accesses the subconscious mind to retrain the immune system, aiming to reduce allergy inflammation and develop resilience to the disease for an extended period. The methodology integrates conventional medicine with complementary and alternative practices, drawing inspiration from psychoneuroimmunology to address each patient's mental state and mindset. Pimea AI is committed to ushering in a new era of allergy relief that prioritizes individual well-being and long-term health.

Headcount over time

From 5 (2023-04) to 3 (2023-09) · -2 (-40%) · 2 points · source: Finder history + radar grounding
50 2023-04 2023-09

Q&A

What is Pimea AI's primary focus?
Pimea AI is developing a digital personalized healthcare therapy for allergies that aims to retrain the immune system to reduce or avoid allergy inflammation by accessing the subconscious mind.
When was Pimea AI founded?
Pimea AI was founded in June 2022.
What is Pimea AI's current funding stage?
Pimea AI is currently in the Pre-Funding stage.
What sector does Pimea AI operate in?
Pimea AI operates in the Health Tech & Life Sciences sector, with additional focus on Digital Healthcare, Digital Therapeutics, Medical Devices, and Medical Treatment & Therapeutics.
What technologies does Pimea AI utilize in its solution?
Pimea AI utilizes technologies such as Sensing, Platforms & Interfaces, Software, and Artificial Intelligence.
Who is the founder and CEO of Pimea AI?
The founder and CEO of Pimea AI is Omer Hevlin.
What is the core methodology behind Pimea AI's treatment?
Pimea AI's methodology is rooted in the modern holistic healthcare paradigm, integrating conventional medicine with complementary and alternative practices, and drawing inspiration from psychoneuroimmunology to address patients' mental states and mindsets.

Team · 1

Omer Hevlin
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingPlatforms & InterfacesSoftwareArtificial Intelligence
Target customers
ConsumersHealthcare & Life SciencesHealthcareProvidersPatients
Business model
B2CB2B2CB2B

Highlights

1 PatentsVerified

Tags

healthcare-providersalgorithmspersonalized-treatmentchronic-patientsautoimmune-diseasesimmunologydigital-therapeuticsdigital-healthcaresoftware-applicationsallergynon-invasivetreatmentsartificial-intelligencedata-analyticsneurologyclinicspharma-companiesmachine-learning
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepimea-ai.com/

Identifiers & details

Founded2022-6
Employees (exact)3

Radar intelligence

Web history (Wayback)

Domainpimea-ai.com

Certificate / subdomain footprint

Subdomains1